Xeris Pharmaceuticals Inc (XERS) — Free Cash Flow Generation Index
Xeris Pharmaceuticals Inc (XERS) has a Free Cash Flow Generation Index of 0.97x as of March 2026. Free cash flow of $9.54 Million represents 1% of operating cash flow ($9.87 Million). Read XERS total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Xeris Pharmaceuticals Inc Free Cash Flow Generation Index (2025–2025)
Historical FCF Generation Index trend for Xeris Pharmaceuticals Inc across 1 annual periods. Explore XERS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Xeris Pharmaceuticals Inc (2025–2025)
Year-by-year Free Cash Flow Generation Index for Xeris Pharmaceuticals Inc. For the full company profile including market capitalisation, see XERS company net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.98x | $27.93 Million | $28.63 Million | $696.00K | — |